Antibody-Drug Conjugate-Based Therapeutics: State of the Science von Birrer, Michael J, Moore, Kathleen N, Betella, Ilaria, Bates, Richard C

Volltext

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group von ALSOP, Kathryn, FEREDAY, Sian, FRIEDLANDER, Michael, FOX, Stephen, BOWTELL, David, MITCHELL, Gillian, MELDRUM, Cliff, DEFAZIO, Anna, EMMANUEL, Catherine, GEORGE, Joshy, DOBROVIC, Alexander, BIRRER, Michael J, WEBB, Penelope M, STEWART, Colin

Volltext

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial von Mirza, Mansoor Raza, MD, Åvall Lundqvist, Elisabeth, PhD, Birrer, Michael J, Prof, dePont Christensen, Rene, PhD, Nyvang, Gitte-Bettina, MD, Malander, Susanne, PhD, Anttila, Maarit, PhD, Werner, Theresa L, MD, Lund, Bente, MD, Lindahl, Gabriel, MD, Hietanen, Sakari, PhD, Peen, Ulla, MD, Dimoula, Maria, MD, Roed, Henrik, DMSci, Ør Knudsen, Anja, MD, Staff, Synnöve, PhD, Krog Vistisen, Anders, MD, Bjørge, Line, Prof, Mäenpää, Johanna U, Prof

Volltext

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer von Burger, Robert A, Brady, Mark F, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Huang, Helen, Mannel, Robert S, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew, Birrer, Michael J, Liang, Sharon X

Volltext

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells von Yazinski, Stephanie A, Comaills, Valentine, Buisson, Rémi, Genois, Marie-Michelle, Nguyen, Hai Dang, Ho, Chu Kwen, Todorova Kwan, Tanya, Morris, Robert, Lauffer, Sam, Nussenzweig, André, Ramaswamy, Sridhar, Benes, Cyril H, Haber, Daniel A, Maheswaran, Shyamala, Birrer, Michael J, Zou, Lee

Volltext

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Per... von Moore, Kathleen N, Martin, Lainie P, O'Malley, David M, Matulonis, Ursula A, Konner, Jason A, Perez, Raymond P, Bauer, Todd M, Ruiz-Soto, Rodrigo, Birrer, Michael J

Volltext

Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes von Ghosh, Debadyuti, Bagley, Alexander F., Na, Young Jeong, Birrer, Michael J., Bhatia, Sangeeta N., Belcher, Angela M.

Volltext

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study von Norquist, Barbara M, Brady, Mark F, Harrell, Maria I, Walsh, Tom, Lee, Ming K, Gulsuner, Suleyman, Bernards, Sarah S, Casadei, Silvia, Burger, Robert A, Tewari, Krishnansu S, Backes, Floor, Mannel, Robert S, Glaser, Gretchen, Bailey, Cheryl, Rubin, Stephen, Soper, John, Lankes, Heather A, Ramirez, Nilsa C, King, Mary Claire, Birrer, Michael J, Swisher, Elizabeth M

Volltext

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance von Leung, Cecilia S, Yeung, Tsz-Lun, Yip, Kay-Pong, Wong, Kwong-Kwok, Ho, Samuel Y, Mangala, Lingegowda S, Sood, Anil K, Lopez-Berestein, Gabriel, Sheng, Jianting, Wong, Stephen Tc, Birrer, Michael J, Mok, Samuel C

Volltext

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis von Sosulski, Amanda, Horn, Heiko, Zhang, Lihua, Coletti, Caroline, Vathipadiekal, Vinod, Castro, Cesar M, Birrer, Michael J, Nagano, Osamu, Saya, Hideyuki, Lage, Kasper, Donahoe, Patricia K, Pépin, David

Volltext

Early Events in the Pathogenesis of Epithelial Ovarian Cancer von LANDEN, Charles N, BIRRER, Michael J, SOOD, Anil K

Volltext

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer von Vathipadiekal, Vinod, Saxena, Deepa, Mok, Samuel C, Hauschka, Peter V, Ozbun, Laurent, Birrer, Michael J

Volltext

Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence von Tao, Zhimin, Dang, Xiangnan, Huang, Xing, Muzumdar, Mandar D, Xu, Eric S, Bardhan, Neelkanth Manoj, Song, Haiqin, Qi, Ruogu, Yu, Yingjie, Li, Ting, Wei, Wei, Wyckoff, Jeffrey, Birrer, Michael J, Belcher, Angela M., Ph.D, Ghoroghchian, P. Peter, M.D., Ph.D

Volltext

Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents von Xiao, Haihua, Qi, Ruogu, Li, Ting, Awuah, Samuel G, Zheng, Yaorong, Wei, Wei, Kang, Xiang, Song, Haiqin, Wang, Yongheng, Yu, Yingjie, Bird, Molly A, Jing, Xiabin, Yaffe, Michael B, Birrer, Michael J, Ghoroghchian, P. Peter

Volltext

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer von Qi, Ruogu, Wang, Yongheng, Bruno, Peter M., Xiao, Haihua, Yu, Yingjie, Li, Ting, Lauffer, Sam, Wei, Wei, Chen, Qixian, Kang, Xiang, Song, Haiqin, Yang, Xi, Huang, Xing, Detappe, Alexandre, Matulonis, Ursula, Pepin, David, Hemann, Michael T., Birrer, Michael J., Ghoroghchian, P. Peter

Volltext

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer von Wei, Wei, Mok, Samuel C, Oliva, Esther, Kim, Sung-hoon, Mohapatra, Gayatry, Birrer, Michael J

Volltext

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer von Wei, Wei, Birrer, Michael J.

Volltext

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer von Merritt, William M, Lin, Yvonne G, Han, Liz Y, Kamat, Aparna A, Spannuth, Whitney A, Schmandt, Rosemarie, Urbauer, Diana, Pennacchio, Len A, Cheng, Jan-Fang, Nick, Alpa M, Deavers, Michael T, Mourad-Zeidan, Alexandra, Wang, Hua, Mueller, Peter, Lenburg, Marc E, Gray, Joe W, Mok, Samuel, Birrer, Michael J, Lopez-Berestein, Gabriel, Coleman, Robert L, Bar-Eli, Menashe, Sood, Anil K

Volltext

Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine von Matulonis, Ursula A, Birrer, Michael J, O'Malley, David M, Moore, Kathleen N, Konner, Jason, Gilbert, Lucy, Martin, Lainie P, Bauer, Todd M, Oza, Amit M, Malek, Karim, Pinkas, Jan, Kim, Stella K

Volltext

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer von Moore, Kathleen N, Vergote, Ignace, Oaknin, Ana, Colombo, Nicoletta, Banerjee, Susana, Oza, Amit, Pautier, Patricia, Malek, Karim, Birrer, Michael J

Volltext